MiR-1-5p targets TGF-?R1 and is suppressed in the hypertrophying hearts of rats with pulmonary arterial hypertension.
Ontology highlight
ABSTRACT: The microRNA miR-1 is an important regulator of muscle phenotype including cardiac muscle. Down-regulation of miR-1 has been shown to occur in left ventricular hypertrophy but its contribution to right ventricular hypertrophy in pulmonary arterial hypertension are not known. Previous studies have suggested that miR-1 may suppress transforming growth factor-beta (TGF-?) signalling, an important pro-hypertrophic pathway but only indirect mechanisms of regulation have been identified. We identified the TGF-? type 1 receptor (TGF-?R1) as a putative miR-1 target. We therefore hypothesized that miR-1 and TGF-?R1 expression would be inversely correlated in hypertrophying right ventricle of rats with pulmonary arterial hypertension and that miR-1 would inhibit TGF-? signalling by targeting TGF-?R1 expression. Quantification of miR-1 and TGF-?R1 in rats treated with monocrotaline to induce pulmonary arterial hypertension showed appropriate changes in miR-1 and TGF-?R1 expression in the hypertrophying right ventricle. A miR-1-mimic reduced enhanced green fluorescent protein expression from a reporter vector containing the TGF-?R1 3'- untranslated region and knocked down endogenous TGF-?R1. Lastly, miR-1 reduced TGF-? activation of a (mothers against decapentaplegic homolog) SMAD2/3-dependent reporter. Taken together, these data suggest that miR-1 targets TGF-?R1 and reduces TGF-? signalling, so a reduction in miR-1 expression may increase TGF-? signalling and contribute to cardiac hypertrophy.
SUBMITTER: Connolly M
PROVIDER: S-EPMC7048278 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA